Home/Pipeline/Research Collaboration with OliX Pharmaceuticals

Research Collaboration with OliX Pharmaceuticals

CNS Disorders

ResearchActive

Key Facts

Indication
CNS Disorders
Phase
Research
Status
Active
Company

About Vect-Horus

Vect-Horus is a private, clinical-stage biotech specializing in overcoming major drug delivery challenges, especially for neurological disorders. Its core technology platform utilizes engineered vectors to shuttle therapeutics across biological barriers like the blood-brain barrier, unlocking new treatment possibilities for CNS conditions and other diseases. The company has established significant validation through strategic partnerships with industry leaders like Ionis Pharmaceuticals and OliX Pharmaceuticals, positioning it as a key enabler in the targeted delivery space. While pre-revenue from product sales, its business model is based on research collaborations and licensing agreements to advance partnered programs.

View full company profile

Therapeutic Areas

Other CNS Disorders Drugs

DrugCompanyPhase
NanoBUP™NanopharmaceuticsClinical
PRX-3140NanopharmaceuticsClinical
NP-18-2NanopharmaceuticsClinical
NP-18-3NanopharmaceuticsClinical
LPH-48LophoraPre-clinical
ANAVEX®1-41Anavex Life SciencesPreclinical
New Discovery ProgramsCAMP4 TherapeuticsDiscovery
Next-Gen α7 NAM ProgramNeuphoria TherapeuticsDiscovery/Preclinical